Macro Group Pharmaceutical 9-Month Consol Profit Rises
MACRO GROUP PHARMACEUTICAL MCRO:
NINE-MONTH CONSOL NET PROFIT AFTER TAX EGP 129.5 MILLION VERSUS EGP 106.8 MILLION YEAR AGO
NINE-MONTH CONSOL REVENUE EGP 520.3 MILLION VERSUS EGP 417.1 MILLION YEAR AGO